Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence

Overview of attention for article published in BMC Medicine, December 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 13,323 followers.

A new paper in @BMCMedicine from our faculty @CBGood23 and @ihdezdelso examines the cost-effectiveness of herpes zoster vaccinations. @pittpharmacy https://t.co/IaFW4Cv1pR

18 Dec 2018

Reply Repost Favourite

RT @ihdezdelso: Our commentary on the latest cost-effectiveness evidence on herpes zoster vaccines is out in @BMCMedicine https://t.co/XvpN…

18 Dec 2018

Reply Repost Favourite

Our commentary on the latest cost-effectiveness evidence on herpes zoster vaccines is out in @BMCMedicine https://t.co/XvpNg1arH6 As always, a pleasure to write with @CBGood23

18 Dec 2018

Reply Repost Favourite

RT @CBGood23: Our paper is out in BMC Medicine today: Avoiding Rash Decisions about Zoster Vaccination. https://t.co/NSdRODWqev @ihdezdels…

18 Dec 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.